Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co (LLY), maintaining a price target of $815. This reaffirmation underscores the analyst's positive outlook on the company's stock.
April 18, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirms an Overweight rating on Eli Lilly with a $815 price target, indicating a strong confidence in the company's future stock performance.
The reiteration of an Overweight rating by a reputable analyst, along with a high price target, suggests a bullish outlook for Eli Lilly. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100